|4Jun 21, 5:03 PM ET

Feigal Ellen 4

4 · NextCure, Inc. · Filed Jun 21, 2024

Insider Transaction Report

Form 4
Period: 2024-06-20
Feigal Ellen
Director
Transactions
  • Award

    Stock Option (Right to Buy)

    2024-06-20+18,70018,700 total
    Exercise: $1.50Exp: 2034-06-19Common Stock (18,700 underlying)
Footnotes (1)
  • [F1]The option vests in full on the earlier of June 20, 2025 and the date of the 2025 Annual Meeting of Stockholders.

Documents

1 file
  • 4
    form4.xmlPrimary